Trials / Conditions / Anal Canal Squamous Cell Carcinoma
Anal Canal Squamous Cell Carcinoma
5 registered clinical trials studyying Anal Canal Squamous Cell Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer NCT04499352 | Boehringer Ingelheim | Phase 2 |
| Active Not Recruiting | Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study NCT04166318 | ECOG-ACRIN Cancer Research Group | Phase 2 |
| Completed | Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive NCT03690921 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy NCT03712566 | University Health Network, Toronto | — |
| Active Not Recruiting | Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer NCT02314169 | National Cancer Institute (NCI) | Phase 2 |